FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037040360> ?p ?o ?g. }

• W3037040360 endingPage "267" @default.
• W3037040360 startingPage "255" @default.
• W3037040360 abstract "Introduction: Disruptions of extracellular matrix (ECM) degradation homeostasis play a significant role in the pathogenesis of osteoarthritis (OA). Matrix metalloproteinase 13 (MMP13) and collagen Ⅱ are important components of ECM. Earlier we found that quercitrin could significantly decrease MMP13 gene expression and increase collagen Ⅱ gene expression in IL-1β-induced rat chondrocytes and human chondrosarcoma (SW1353) cells. Objectives: The effects and mechanism of quercitrin on OA were explored. Methods: Molecular mechanisms of quercitrin on OA were studied in vitro in primary chondrocytes and SW1353 cells. An anterior cruciate ligament transection (ACLT) rat model of OA was used to investigate the effect of quercitrin in vivo. Micro-CT analysis and Safranin O-Fast Green Staining of knee joint samples were performed to observe the damage degree of tibial subchondral bone. Immunohistochemistry of knee joint samples were conducted to observe the protein level of MMP13, collagen Ⅱ and p110α in articular cartilage. Results: In vitro, quercitrin promoted cell proliferation and delayed ECM degradation by regulating MMP13 and collagen II gene and protein expressions. Moreover, quercitrin activated the Phosphatidylinositol 3-kinase p110α (p110α)/AKT/mTOR signaling pathway by targeting p110α. We also firstly showed that the gene expression level of p110α was remarkably decreased in cartilage of OA patients. The results showed that intra-articular injection of quercitrin increased bone volume/tissue volume of tibial subchondral bone and cartilage thickness and reduced the Osteoarthritis Research Society International scores in OA rats. Meanwhile, immunohistochemical results showed that quercitrin exerted anti-OA effect by delaying ECM degradation. Conclusion: These findings suggested that quercitrin may be a prospective disease-modifying OA drug for prevention and treatment of early stage OA." @default.
• W3037040360 created "2020-07-02" @default.
• W3037040360 creator A5015515628 @default.
• W3037040360 creator A5016883906 @default.
• W3037040360 creator A5020415816 @default.
• W3037040360 creator A5022197965 @default.
• W3037040360 creator A5055803748 @default.
• W3037040360 creator A5070019426 @default.
• W3037040360 creator A5074889289 @default.
• W3037040360 creator A5090337654 @default.
• W3037040360 date "2021-02-01" @default.
• W3037040360 modified "2023-10-16" @default.
• W3037040360 title "Quercitrin alleviates cartilage extracellular matrix degradation and delays ACLT rat osteoarthritis development: An in vivo and in vitro study" @default.
• W3037040360 cites W1668626243 @default.
• W3037040360 cites W1966700699 @default.
• W3037040360 cites W1976178491 @default.
• W3037040360 cites W1977267072 @default.
• W3037040360 cites W1980297880 @default.
• W3037040360 cites W1980458730 @default.
• W3037040360 cites W1980877245 @default.
• W3037040360 cites W1985004392 @default.
• W3037040360 cites W1987759199 @default.
• W3037040360 cites W1988306530 @default.
• W3037040360 cites W2013425466 @default.
• W3037040360 cites W2030682870 @default.
• W3037040360 cites W2043344789 @default.
• W3037040360 cites W2048630477 @default.
• W3037040360 cites W2056854155 @default.
• W3037040360 cites W2070952973 @default.
• W3037040360 cites W2071693375 @default.
• W3037040360 cites W2081771171 @default.
• W3037040360 cites W2086823687 @default.
• W3037040360 cites W2087012714 @default.
• W3037040360 cites W2089219302 @default.
• W3037040360 cites W2094371980 @default.
• W3037040360 cites W2101471525 @default.
• W3037040360 cites W2106582491 @default.
• W3037040360 cites W2108344016 @default.
• W3037040360 cites W2118073504 @default.
• W3037040360 cites W2122558784 @default.
• W3037040360 cites W2124032632 @default.
• W3037040360 cites W2138960046 @default.
• W3037040360 cites W2279237194 @default.
• W3037040360 cites W2342181111 @default.
• W3037040360 cites W2345330021 @default.
• W3037040360 cites W2410342253 @default.
• W3037040360 cites W2415156585 @default.
• W3037040360 cites W2428034714 @default.
• W3037040360 cites W2437888655 @default.
• W3037040360 cites W2481203471 @default.
• W3037040360 cites W2525392583 @default.
• W3037040360 cites W2563112419 @default.
• W3037040360 cites W2598705813 @default.
• W3037040360 cites W2599413800 @default.
• W3037040360 cites W2608899726 @default.
• W3037040360 cites W2611772358 @default.
• W3037040360 cites W2612032370 @default.
• W3037040360 cites W2668593039 @default.
• W3037040360 cites W2697128618 @default.
• W3037040360 cites W2748685928 @default.
• W3037040360 cites W2757745372 @default.
• W3037040360 cites W2761855731 @default.
• W3037040360 cites W2767166610 @default.
• W3037040360 cites W2782408936 @default.
• W3037040360 cites W2894318233 @default.
• W3037040360 cites W2941727130 @default.
• W3037040360 cites W2971102494 @default.
• W3037040360 cites W2974242780 @default.
• W3037040360 cites W4211069396 @default.
• W3037040360 cites W4295837929 @default.
• W3037040360 doi "https://doi.org/10.1016/j.jare.2020.06.020" @default.
• W3037040360 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7753236" @default.
• W3037040360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33364061" @default.
• W3037040360 hasPublicationYear "2021" @default.
• W3037040360 type Work @default.
• W3037040360 sameAs 3037040360 @default.
• W3037040360 citedByCount "21" @default.
• W3037040360 countsByYear W30370403602021 @default.
• W3037040360 countsByYear W30370403602022 @default.
• W3037040360 countsByYear W30370403602023 @default.
• W3037040360 crossrefType "journal-article" @default.
• W3037040360 hasAuthorship W3037040360A5015515628 @default.
• W3037040360 hasAuthorship W3037040360A5016883906 @default.
• W3037040360 hasAuthorship W3037040360A5020415816 @default.
• W3037040360 hasAuthorship W3037040360A5022197965 @default.
• W3037040360 hasAuthorship W3037040360A5055803748 @default.
• W3037040360 hasAuthorship W3037040360A5070019426 @default.
• W3037040360 hasAuthorship W3037040360A5074889289 @default.
• W3037040360 hasAuthorship W3037040360A5090337654 @default.
• W3037040360 hasBestOaLocation W30370403601 @default.
• W3037040360 hasConcept C105702510 @default.
• W3037040360 hasConcept C142724271 @default.
• W3037040360 hasConcept C150903083 @default.
• W3037040360 hasConcept C185592680 @default.
• W3037040360 hasConcept C189165786 @default.
• W3037040360 hasConcept C197534660 @default.
• W3037040360 hasConcept C204787440 @default.
• W3037040360 hasConcept C207001950 @default.

• next